ZOMD.F Stock Overview
A veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
Zomedica Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.048 |
| 52 Week High | US$0.20 |
| 52 Week Low | US$0.015 |
| Beta | 1.16 |
| 1 Month Change | -60.43% |
| 3 Month Change | -61.87% |
| 1 Year Change | -65.22% |
| 3 Year Change | -84.76% |
| 5 Year Change | -73.54% |
| Change since IPO | -94.21% |
Recent News & Updates
Recent updates
Shareholder Returns
| ZOMD.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -54.1% | -0.8% | -1.9% |
| 1Y | -65.2% | 9.3% | 14.0% |
Return vs Industry: ZOMD.F underperformed the US Medical Equipment industry which returned 9.3% over the past year.
Return vs Market: ZOMD.F underperformed the US Market which returned 14% over the past year.
Price Volatility
| ZOMD.F volatility | |
|---|---|
| ZOMD.F Average Weekly Movement | 16.4% |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 17.2% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: ZOMD.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: ZOMD.F's weekly volatility has increased from 10% to 16% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 144 | Larry Heaton | www.zomedica.com |
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system. It also provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line of products, including the Assisi Loop, Assisi Loop Lounge, and DentaLoop devices that treat pain and inflammation through delivery of targeted pulsed electromagnetic field focused energy.
Zomedica Corp. Fundamentals Summary
| ZOMD.F fundamental statistics | |
|---|---|
| Market cap | US$47.04m |
| Earnings (TTM) | -US$62.19m |
| Revenue (TTM) | US$26.73m |
1.8x
P/S Ratio-0.8x
P/E RatioIs ZOMD.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ZOMD.F income statement (TTM) | |
|---|---|
| Revenue | US$26.73m |
| Cost of Revenue | US$8.12m |
| Gross Profit | US$18.61m |
| Other Expenses | US$80.81m |
| Earnings | -US$62.19m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Mar 13, 2025
| Earnings per share (EPS) | -0.063 |
| Gross Margin | 69.64% |
| Net Profit Margin | -232.70% |
| Debt/Equity Ratio | 0% |
How did ZOMD.F perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/06 20:28 |
| End of Day Share Price | 2025/03/05 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Zomedica Corp. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert LeBoyer | NOBLE Capital Markets, Inc. |